EP3833381
MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS ADMINISTRATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.8.2020:
3.8.2022:
20762011.3
:
14.8.2040
:
MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS ADMINISTRATION
15.8.2020
3.8.2022
:
Catalyst Biosciences, Inc.:
611 Gateway Blvd., Suite 710, South San Francisco, CA 94080, US
:
BLOUSE, Grant E.:
Burlingame, California 94010, US
:
KNUDSEN, Tom:
Burlingame, California 94010, US
:
LEVY, Howard:
Hopewell, New Jersey 08525, US
:
201962887599 P:
15.8.2019:
US
:
202062970152 P:
4.2.2020:
US
:
202063010656 P:
15.4.2020:
US
:
US2020046577:
15.8.2020
:
A61K 38/48, A61P 7/04